Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Consroe

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Psychopharmacology|January 1, 1979
Interaction of cannabidiol and alcohol in humansP Consroe, E A Carlini, A P Zwicker, et al.
Gastroenterology|August 1, 1977
Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in ArizonaA S Stillman, R Huxtable, P Consroe, et al.
European Journal of Pharmacology|September 24, 1982
Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in miceP Consroe, M A Benedito, J R Leite, et al.
European Journal of Pharmacology|April 4, 1997
delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brainT H Burkey, R M Quock, P Consroe, et al.
European Journal of Pharmacology|November 5, 1997
SR141716A is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, T H Burkey, P Consroe, et al.
The International Journal of Neuroscience|January 1, 1988
Intraspinal opiates for treatment of intractable pain in the terminally ill cancer patientR P Iacono, J Linford, R Sandyk, et al.
Life Sciences|March 13, 1998
AM630 is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, A Makriyannis, H Deng, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1991
Controlled clinical trial of cannabidiol in Huntington's diseaseP Consroe, J Laguna, J Allender, et al.
European Journal of Pharmacology|February 19, 1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brainY Hosohata, R M Quock, K Hosohata, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Psychopharmacology|January 1, 1979
Interaction of cannabidiol and alcohol in humansP Consroe, E A Carlini, A P Zwicker, et al.
Gastroenterology|August 1, 1977
Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in ArizonaA S Stillman, R Huxtable, P Consroe, et al.
European Journal of Pharmacology|September 24, 1982
Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in miceP Consroe, M A Benedito, J R Leite, et al.
European Journal of Pharmacology|April 4, 1997
delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brainT H Burkey, R M Quock, P Consroe, et al.
European Journal of Pharmacology|November 5, 1997
SR141716A is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, T H Burkey, P Consroe, et al.
The International Journal of Neuroscience|January 1, 1988
Intraspinal opiates for treatment of intractable pain in the terminally ill cancer patientR P Iacono, J Linford, R Sandyk, et al.
Life Sciences|March 13, 1998
AM630 is an inverse agonist at the human cannabinoid CB1 receptorR S Landsman, A Makriyannis, H Deng, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1991
Controlled clinical trial of cannabidiol in Huntington's diseaseP Consroe, J Laguna, J Allender, et al.
European Journal of Pharmacology|February 19, 1997
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brainY Hosohata, R M Quock, K Hosohata, et al.
NIDA Research Monograph|January 1, 1987
Stereochemical requirements for cannabimimetic activityR Mechoulam, N Lander, M Srebnik, et al.
Pageof 5